Dimphna van Reijen

Reduced Cancer Incidence in Huntington’s Disease: Analysis in the Registry Study

Paul McNulty, Richard Pilcher, Renata Necuiniate, Alis Hughes et autres

BACKGROUND: People with Huntington's disease (HD) have been observed to have lower rates of cancers. OBJECTIVE: To investigate the relationship between age of onset of HD, CAG repeat length, and cancer diagnosis. METHODS: Data were obtained from the European Huntington's disease network …

gb, at, de, fr, be, cz, dk, ax, se, fi (code pays fourni par la source)

Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study

Davina J. Hensman Moss, Antonio F. Pardiñas, Douglas R. Langbehn, Kitty Lo et autres

gb, us, ca, nl, fr (code pays fourni par la source)

Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease

Koen Poesen, Maxim De Schaepdryver, Beatrice Stubendorff, Benjamin Gille et autres

OBJECTIVE: To determine the diagnostic performance and prognostic value of phosphorylated neurofilament heavy chain (pNfH) and neurofilament light chain (NfL) in CSF as possible biomarkers for amyotrophic lateral sclerosis (ALS) at the diagnostic phase. METHODS: We measured CSF pNfH and NfL concentrations …

de, be (code pays fourni par la source)

Prognostic value of clinical and electrodiagnostic parameters at time of diagnosis in patients with amyotrophic lateral sclerosis

Wendeline Reniers, Maarten Schrooten, Kristl G. Claeys, Petra Tilkin et autres

OBJECTIVE: To assess the added prognostic value of the aggregated clinical and electrodiagnostic data, which define a given diagnostic category according to the Awaji or revised El Escorial criteria at time of diagnosis in patients with amyotrophic lateral sclerosis (ALS). METHODS: Clinical …

be (code pays fourni par la source)